Clinical Trial Update: Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of multiple doses of BT061 in adults with moderate-to-severe chronic plaque psoriasis has completed, with rep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• BT061

Snippet

Sponsor: Biotest | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED